They then compared the pattern of gene abnormalities in the initial
myeloma tissue and the metastatic tumors.
Not exact matches
To unravel exactly how ADAR1 is connected to disease severity at a molecular level, the researchers transferred multiple
myeloma patient
tissue to mice, creating what's known as a xenograft or «humanized» model.
Using their new model, Jamieson, Crews and team found that two events converge to activate ADAR1 in multiple
myeloma — a genetic abnormality and inflammatory cues from the surrounding bone marrow
tissue.
Researchers used
tissue and blood samples to show that the gammopathy (a precursor to
myeloma) in both mice and patients with Gaucher disease is triggered by specific lipids, and that the antibodies made by tumor cells in nearly a third of
myeloma patients are directed against such lipids.
Senior author Madhav Dhodapkar, M.D., the Arthur H. and Isabel Bunker Professor of Medicine and Immunobiology, and chief of Hematology, said the study, using
tissue and blood samples from humans and mice, shows that chronic stimulation of the immune system by lipids made in the context of inflammation underlies the origins of at least a third of all
myeloma cases.
Plasma cell neoplasms are diseases in which abnormal plasma cells or
myeloma cells form tumors in the bones or soft
tissues of the body.
Elusive Cancer Stem Cell Identified Johns Hopkins Kimmel Cancer Center scientists have identified the cell likely to be responsible for the development of multiple
myeloma, a cancer of the bone marrow that destroys bone
tissue.